| PERIOD ENDING | 31-Mar-09 | 31-Jan-09 | 31-Dec-08 | 31-Oct-08 | | Total Revenue | 10,371 | 23,851 | 20,390 | 12,085 | | Cost of Revenue | 7,517 | 17,135 | 14,539 | 7,402 | | | Gross Profit | 2,854 | 6,716 | 5,851 | 4,683 | | | Operating Expenses | | Research Development | 1,594 | 1,586 | 1,048 | 1,480 | | Selling General and Administrative | 4,420 | 5,036 | 3,640 | 4,466 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,160) | 94 | 1,163 | (1,263) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,307) | 634 | 618 | 782 | | Earnings Before Interest And Taxes | (7,467) | 728 | 1,781 | (481) | | Interest Expense | 23 | 55 | 47 |
-
| | Income Before Tax | (7,490) | 673 | 1,734 | (481) | | Income Tax Expense | (64) | 142 | 209 | (36) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,426) | 531 | 1,525 | (445) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,426) | 531 | 1,525 | (445) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,426) | $531 | $1,525 | ($445) |
|
0.51% Nasdaq 
Income Statement
